NCT06409052Recruiting
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 45 (estimated)
- First submitted
- 7 May 2024
- Start date
- 25 Jun 2024
- Primary completion date
- 30 Aug 2030
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Endometrial cancer
- NCT number
- NCT06409052
What you commit to
- Study type: Observational
- Planned participants: 45
- From 25 Jun 2024 to the primary completion date, 30 Aug 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer
- Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia
- Women without a diagnosis of endometrial cancer or endometrial hyperplasia
- Women must be at least 18 years or age
- Women must be able to read, write, and speak English
- Women must be willing and able to provide written informed consent
Age in the registry: 18 years to - · Sex: Female
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.